Skip to main content
. 2020 Mar 26;12(4):787. doi: 10.3390/cancers12040787

Figure 7.

Figure 7

Correlation of IDH1 mutation and cancer aggressiveness. Pathogenic IDH1 mutation depletes cellular metabolism through D-2-hydroxyglutarate (D-2-HG) production, which contributes to an aggressive phenotype in cancer cells. The mTORC2/Rac1 pathway and concomitant cytoskeleton mobilization promote cellular food-seeking, motility, chemotaxis, and endocytosis.